Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04179396
Title Study of Oral Rucaparib With Other Anticancer Agents in Metastatic Castration Resistant Prostate Cancer Patients (RAMP) (RAMP)
Recruitment Active, not recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors Clovis Oncology, Inc.
Indications

prostate adenocarcinoma

prostate carcinoma

Therapies

Enzalutamide + Rucaparib

Abiraterone + Rucaparib

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.